secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001613103-23-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic Q4 revenue beats at $8.5B (+5.6%); raises dividend to $0.69 quarterly
-------------------------------------------------------------------------------

- Q4 GAAP EPS $0.88 (-20% YoY); non-GAAP EPS $1.57 (+3%), ahead of expectations.
- FY23 revenue $31.2B (-1.4% reported, +2.1% organic); FY organic growth guided 4.0-4.5%.
- Dividend increased to $0.69/share quarterly ($2.76 annual); 46th consecutive annual increase.
- Announced definitive agreement to acquire EOFlow Co. Ltd. (EOPatch tubeless insulin pump).
- FY24 non-GAAP EPS guidance $5.00-$5.10; revenue positively impacted by FX ~$110-210M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000032/0001613103-23-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000032/mdt-20230525.htm
  HTML page:      https://secwatch.observer/filing/0001613103-23-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer